ProtonIntel
Transforming Hyperkalemia Management
Vancouver, Canada · Founded 2020 · $7.0M raised
- Headquarters
- Vancouver
- Employees
- 11–50
- Founded
- 2020
- Business Model
- B2B
- Website
- protonintel.com
- Total Funding
- $7.0M
- Last Round
- $7.0M SeedDec 2024
- Rounds
- 1
About
Proton Intelligence is developing the first real-time, on-demand potassium monitoring wearable for patients with hyperkalemia and chronic kidney disease. Hyperkalemia — elevated blood potassium — affects more than 3.7 million Americans and is strongly associated with cardiac events. Current treatment is hampered by the lack of continuous potassium monitoring tools; the Proton Intelligence device aims to allow clinicians to treat and manage kidney disease patients more safely and precisely by providing dynamic, wearable-based K+ readings without requiring lab draws.
Summary
ProtonIntel is a Healthcare company based in Vancouver, Canada, founded in 2020. It has raised $7.0M in total across 1 round, most recently a $7.0M Seed round in Dec 2024. Investors include SOSV, Tenmile and LongeVC.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2024
Investors
Similar Companies
Fitness wearable company offering a subscription-based health tracker that measures strain, recov...

PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...
Telehealth platform providing personalized health and wellness treatments for men and women, cove...
Digital health insurance company and healthcare super-app offering personalized health insurance,...
European digital healthcare platform connecting patients with licensed doctors via video consulta...

Digital healthcare platform connecting patients, hospitals, and doctors in China for online consu...